GenomOncology’s VP of Product Innovation, Matthew Stachowiak, and Genomenon’s Senior Manager of Customer Success, Denice Belandres, will demonstrate how GenomOncology’s reporting capabilities combined with Genomenon’s data, powers a new standard in genomic variant interpretation for clinical labs.
What You’ll Learn:
- How real-time, AI-indexed evidence—spanning over 27 million variants and 10 million full-text articles—and expertly curated content, following ACMG guidelines, facilitate in-depth variant-level analysis, helping labs surface critical insights missed by standard tools and reduce curation time.
- How Genomenon’s Mastermind Flex Data seamlessly integrates into lab workflows to accelerate VUS resolution, enhance diagnostic confidence, and raise the bar for clinical accuracy, speed, and scalability.
- How somatic variant data from Genomenon’s Cancer Knowledgebase (CKB) is leveraged by partners like GenomOncology to enhance cancer interpretation—ensuring both germline and somatic pipelines benefit from the most comprehensive, real-time genomic evidence available.
